Price target
Based on analysts projections #LGND is expected to experience a positive growth trajectory over the next year.
The current average LGND price target, as estimated by these analysts, is $90.00.
The predictions for the future LGND stock price range from a low of $90.00 to a high of $90.00, highlighting the variability of market expectations for LGND.
It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.
LGND stock forecasts by analyst
Analyst / firm | Date | Rating | Price target | Price when posted |
---|---|---|---|---|
Roth Capital | December 23, 2022 | Buy | 90.00 | 67.32 |
Ligand Pharmaceuticals (LGND) Fundamentals Checker
Financial metrics are used to evaluate financial stability which helps analysts determine if Ligand Pharmaceuticals is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.
Buy

Financial Scores
Updated on: 07/12/2023
Altman Z-Score: 7.4
Piotroski Score: 7.0
ESG Score
Updated on: 07/12/2023
Environmental: 74.6
Social: 70.1
Governance: 76.5
Financial Health
Updated on: 07/12/2023
DCF: Strong Buy
ROE: Neutral
ROA: Neutral
Debt to equity ratio: Neutral
Price to earnings ratio: Strong Buy
Price to book ratio: Strong Buy
LGND Discounted Cash Flow
Updated on: 07/12/2023
$79.669
Discounted Cash Flow Value
$59.770
Current Price
LGND Revenues by Segment
Updated on: 07/12/2023
Revenue from Contract with Customer, Excluding Assessed Tax
LGND Revenues by Region
Updated on: 07/12/2023
No available data
LGND Notes Due
Updated on: 07/12/2023
CIK | Exchange | Title |
---|---|---|
0000886163 | NASDAQ | Preferred Share Purchase Rights |
0000886163 | PNK | Preferred Share Purchase Rights |
Ligand Pharmaceuticals (LGND) Social Sentiments
Monitoring bullish and bearish sentiments towards Ligand Pharmaceuticals on Twitter and Stocktwits could help to forecast an upward or downward trend in Ligand Pharmaceuticals stock price.